Pang Y - Search Results

1

Pang Y, Young CY, Yuan H. Pang Y, et al. Acta Biochim Biophys Sin (Shanghai). 2010 Jun 15;42(6):363-9. doi: 10.1093/abbs/gmq038. Acta Biochim Biophys Sin (Shanghai). 2010. PMID: 20539944 Free article. Review.

2

Autophagy inhibition promotes paclitaxel-induced apoptosis in cancer cells.

Xi G, Hu X, Wu B, Jiang H, Young CY, Pang Y, Yuan H. Xi G, et al. Among authors: pang y. Cancer Lett. 2011 Aug 28;307(2):141-8. doi: 10.1016/j.canlet.2011.03.026. Epub 2011 Apr 21. Cancer Lett. 2011. PMID: 21511395

3

DHA2, a synthesized derivative of bisbibenzyl, exerts antitumor activity against ovarian cancer through inhibition of XIAP and Akt/mTOR pathway.

Pang Y, Si M, Sun B, Niu L, Xu X, Lu T, Yuan H, Lou H. Pang Y, et al. Food Chem Toxicol. 2014 Jul;69:163-74. doi: 10.1016/j.fct.2014.04.010. Epub 2014 Apr 18. Food Chem Toxicol. 2014. PMID: 24751974

4

Roles of NPAS2 in circadian rhythm and disease.

Peng LU, Bai G, Pang Y. Peng LU, et al. Among authors: pang y. Acta Biochim Biophys Sin (Shanghai). 2021 Oct 12;53(10):1257-1265. doi: 10.1093/abbs/gmab105. Acta Biochim Biophys Sin (Shanghai). 2021. PMID: 34415290 Free article. Review.

5

Prognostic and therapeutic implications of increased ATP citrate lyase expression in human epithelial ovarian cancer.

Wang Y, Wang Y, Shen L, Pang Y, Qiao Z, Liu P. Wang Y, et al. Among authors: pang y. Oncol Rep. 2012 Apr;27(4):1156-62. doi: 10.3892/or.2012.1638. Epub 2012 Jan 16. Oncol Rep. 2012. PMID: 22266777 Free PMC article.

6

MiR-519d represses ovarian cancer cell proliferation and enhances cisplatin-mediated cytotoxicity in vitro by targeting XIAP.

Pang Y, Mao H, Shen L, Zhao Z, Liu R, Liu P. Pang Y, et al. Onco Targets Ther. 2014 Apr 23;7:587-97. doi: 10.2147/OTT.S60289. eCollection 2014. Onco Targets Ther. 2014. PMID: 24790458 Free PMC article.

7

Ectopic repression of receptor tyrosine kinase-like orphan receptor 2 inhibits malignant transformation of ovarian cancer cells by reversing epithelial-mesenchymal transition.

Xu Y, Ma YH, Pang YX, Zhao Z, Lu JJ, Mao HL, Liu PS. Xu Y, et al. Among authors: pang yx. Tumour Biol. 2017 May;39(5):1010428317701627. doi: 10.1177/1010428317701627. Tumour Biol. 2017. PMID: 28475014 Free article.

8

Smac peptide potentiates TRAIL- or paclitaxel-mediated ovarian cancer cell death in vitro and in vivo.

Mao HL, Pang Y, Zhang X, Yang F, Zheng J, Wang Y, Liu P. Mao HL, et al. Among authors: pang y. Oncol Rep. 2013 Feb;29(2):515-22. doi: 10.3892/or.2012.2132. Epub 2012 Nov 9. Oncol Rep. 2013. PMID: 23151974

9

Update of research on the role of EZH2 in cancer progression.

Shen L, Cui J, Liang S, Pang Y, Liu P. Shen L, et al. Among authors: pang y. Onco Targets Ther. 2013 Apr 4;6:321-4. doi: 10.2147/OTT.S42453. Print 2013. Onco Targets Ther. 2013. PMID: 23589697 Free PMC article.

10

Celecoxib induces epithelial-mesenchymal transition in epithelial ovarian cancer cells via regulating ZEB1 expression.

Liu R, Zheng J, Li C, Pang Y, Zheng Q, Xu X, Liu P. Liu R, et al. Among authors: pang y. Arch Gynecol Obstet. 2015 Jun;291(6):1361-9. doi: 10.1007/s00404-014-3555-3. Epub 2014 Nov 26. Arch Gynecol Obstet. 2015. PMID: 25424898

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,796 results

Search Page